Home>Etornext P>etornext p 400 mg/325 mg tablet

Etornext P 400 mg/325 mg Tablet

icon
Alembic Pharmaceuticals Ltd

Composition for Etornext P 400 mg/325 mg Tablet

iconPrescription Required

Primary uses of Etornext P 400 mg/325 mg Tablet

Potentiallyunsafewith
icon
Alcohol
BANNED FOR SALE
As per the Drugs and Cosmetics Act, Ministry of Health and Family Welfare

Medicine Overview of Etornext P Tablet

uses

Uses of Etornext P Tablet

Etornext P 400 mg/325 mg Tablet is used in the treatment of pain relief.
uses

Etornext P Tablet side effects

Common

Nausea, Diarrhoea, Stomach pain / epigastric pain, Loss of appetite, Heartburn.

uses

How to use Etornext P Tablet

Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Etornext P 400 mg/325 mg Tablet is to be taken with food.

How Etornext P Tablet works

Etornext P 400 mg/325 mg Tablet is a combination of two medicines: Etodolac and Paracetamol which relieve pain. They work by blocking the release of certain chemical messengers in the brain that are responsible for pain and fever.

In Depth Information on Etornext P Tablet

Etornext P Tablet related warnings
Special precautions for Etornext P Tablet
Alcohol
CAUTION
Taking Etodolac+Paracetamol with alcohol can cause liver damage.
Pregnancy
WEIGH RISKS VS BENEFITS
Etornext P 400 mg/325 mg Tablet may be unsafe to use during pregnancy.
Animal studies have shown adverse effects on the foetus, however, there are limited human studies. The benefits from use in pregnant women may be acceptable despite the risk. Please consult your doctor.
Lactation
CAUTION
Etornext P 400 mg/325 mg Tablet is probably unsafe to use during lactation. Limited human data suggest that the drug could represent a significant risk to the baby.
Driving
Etornext P 400 mg/325 mg Tablet may make you feel dizzy, drowsy or affect your vision. Do not drive until your vision is clear.
Kidney
Etornext P 400 mg/325 mg Tablet is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Etornext P 400 mg/325 mg Tablet may not be needed in these patients. Please consult your doctor.
Regular monitoring of kidney function tests is advisable while you are taking this medicine.
Liver
CAUTION
Etornext P 400 mg/325 mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Etornext P 400 mg/325 mg Tablet may be needed. Please consult your doctor.
However, the use of Etornext P 400 mg/325 mg Tablet is not recommended in patients with severe liver disease and active liver disease.

Patient Concerns

No Patient Concerns found for this medicine

User Submitted Feedback For Etornext P 400 mg/325 mg Tablet

Survey Participants: 8
Disclaimer
“The following are the results of on-going survey on 1mg.com for Etornext P 400 mg/325 mg Tablet. These results only indicate the perceptions of the website users. Please base your medical decisions only on the advice of a doctor or a registered medical professional.”

Substitutes for Etornext P 400 mg/325 mg Tablet

Etobest P 400mg/325mg Tablet
Intra Labs India Pvt. Ltd.
₹9.5/Tablet
3% costlier
Etolid P 400mg/325mg Tablet
Leeford Healthcare Ltd
₹9.5/Tablet
3% costlier
Stalpol-ET 400mg/325mg Tablet
Stallion Laboratories Pvt Ltd
₹11/Tablet
20% costlier
Myeto P 400mg/325mg Tablet
Arlak Biotech Pvt Ltd
₹13/Tablet
41% costlier
Toldin P Tablet
Torrent Pharmaceuticals Ltd
₹7.58/Tablet
save 18%
Top Rheumatologists
5.0
Dr. Naval Mendiratta
MBBS, MD, Fellowship
4.7
Dr. Prasan Deep Rath
MBBS, MD, Fellowship, Certification, Fellowship
4.4
Dr. Ashok Kumar
MBBS, MD, Fellowship
5.0
Dr. Sumeet Agrawal
MBBS, MD, DM
4.9
cross img